ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Dynamic Fibrous Hydrogels for Stem Cell Homing and In Situ Bone Regeneration.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hydrogel Implementing Drug Delivery in Cranial Bone Tissue Engineering.Journal of functional biomaterials · 2026Review
- An Environmentally Tolerant 5A Hydrogel with Photothermal Effect for Frostbite Treatment.Gels (Basel, Switzerland) · 2026Article
- Dynamic Fibrous Hydrogels for Stem Cell Homing and In Situ Bone Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Stem cell therapy holds great promise for enhancing bone regeneration, but its clinical outcomes are often hampered by ineffective cell homing and compromised paracrine activity in pathological oxidative microenvironments. Here, a dynamic fibrous hydrogel (DFH) is presented, fabricated by covalently crosslinking gelatin with tea-derived trichomes (TH), which recapitulates the static and dynamic features of the native extracellular matrix (ECM) to enhance stem cell-mediated bone repair. DFH features a robust, heterogeneous fibrous network that closely mimics the structural complexity and biochemical composition of the ECM, thereby creating a tailored niche for mesenchymal stem cell (MSC) delivery. Specifically, DFH exhibits potent photothermal responsiveness, enabling spatiotemporal regulation that boosts the paracrine secretion of SDF-1 from encapsulated MSCs, thereby promoting stem cell migration. Furthermore, the polyphenol-rich TH endows DFH with superior antioxidant capabilities, markedly improving MSC survival under oxidative stress. In murine cranial defects, MSC-laden DFH (DFH@MSC) with photothermal stimulation enhances stem cell recruitment, promotes angiogenesis, and reduces inflammation, ultimately driving robust bone regeneration. By integrating ECM-mimetic structural and compositional fidelity with spatiotemporal modulation, DFH introduces a novel "stem cell recruits stem cell" strategy that orchestrates the co-homing of endogenous and exogenous stem cells, establishing a pioneering therapeutic paradigm for in situ tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.